Implantica submits U.S. FDA Premarket Approval (PMA) application for RefluxStop® (first module)

VADUZ, Liechtenstein, March 27, 2024 /PRNewswire/ — Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces the submission of the first module of the PMA application to the U.S. FDA for RefluxStop®, an innovative device for the…